| Study Period | 2019 - 2030 |
| 2024 Market Size | USD 5,357.5 Million |
| 2025 Market Size | USD 5,789.5 Million |
| 2030 Forecast | USD 8,728.0 Million |
| Growth Rate (CAGR) | 8.5% |
| Largest Region | North America |
| Fastest Growing Region | North America |
| Nature of the Market | Fragmented |
| Largest End User Category | Public Access Settings |
|
Explore the market potential with our data-driven report
The external defibrillator market size stood at USD 5,357.5 million in 2024, which is expected to reach USD 8,728.0 million by 2030, advancing at a CAGR of 8.5% during 2024–2030.
This is due to the surging aging population and increasing cases of out-of-hospital cardiac arrest (OHCA). As per the Sudden Cardiac Arrest Foundation, every day, 1,000 people in the U.S. have an out-of-hospital cardiac arrest, 90% of whom die. Further, the American Heart Association (AHA) estimates the yearly mortality in the country from cardiac arrests at over 436,000.
This market has a promising future, as both production and demand are expected to rise over the next decade. Regulatory policies in emerging economies, such as India and Brazil, are facilitating the market, since these countries are more adaptable and business-friendly with less stringent regulations. Defibrillator producers are focusing even more on improving their presence in emerging economies, as competition in developed countries heats up, and taking advantage of significant growth potential and sales for defibrillators in developing nations. Moreover, these economies offer lucrative opportunities to players operating in the market. Below are some highlights of developing areas driving the market:
In 2024, adult patients account for the larger revenue share, of 65%, and this category will also witness the higher CAGR, of 8.7%, over this decade.
With the increasing number of adult patients in comparison to pediatric patients all over the world, the risk of CVDs is increasing. Adults are more prone toward cardiac diseases due to unhealthy lifestyles. Moreover, as age increases, the immune system of an individual started facing problems while fighting diseases. Moreover, each year, approximately 0.1% of the U.S. population experience a medical services-assessed, OHCA. The European region has a similar incidence, ranging from 0.04% to 0.1% of the population.
We have covered the following patient types
The public access settings category dominates the market in 2024, with around 50% revenue share. This category will also witness the fastest growth, at a CAGR of 8.9%, during the forecast period.
The rise in the incidence of SCAs and mandate availability of automated external defibrillators in public access settings are key factors contributing to the growth of the market in this end-user category. For example, the U.S., as well as a number of European and APAC countries, has established legislation requiring the installation of these devices in public spaces. These devices have been implemented in public locations such as community centers, schools, stadiums, health clubs, recreation centers, shopping centers, transportation centers, government buildings, airlines, and offices, as a result of this.
The report offers insights for the following end users:
Drive strategic growth with comprehensive market analysis
In 2024, North America holds the major revenue share, of around 45%, in the market. This region will also grow at the highest rate, of 9.0%, during 2024–2030.
The market in North America is mainly driven by the rising healthcare spending, increasing prevalence of CVDs, surging geriatric population, and growing awareness of the benefits of external defibrillators in the event of VF and pulseless ventricular tachycardia.
For instance, the U.S. government spends a significant portion of its GDP on healthcare every year. According to the National Health Expenditure Accounts (NHEA), the country’s healthcare spending increased to 9.7% (around USD 4.1 trillion) in 2020, from 4.3% in 2019. Furthermore, the NHEA states that the country’s healthcare spending is projected to reach USD 6.0 trillion by 2027, and it is expected to grow at a CAGR of 5.5% during 2022–2030.
Besides, conferences, national programs, and other government initiatives for creating awareness on CVDs are expected to positively impact the market in the North American region. For instance, The American Society for Preventative Cardiology Congress on CVD Prevention will be held in Salt Lake City, Utah, on August 2–4. Similarly, the Canadian Cardiovascular Congress (CCC) 2024 is scheduled for October 24–27 in Vancouver, British Columbia.
The Indian market is expected to grow at a significant pace during the forecast period. The market is primarily driven by several measures taken by public and private organizations to raise awareness about these devices, rise in healthcare expenditure, and strategic developments among market players.
As per government sources, the per-capita healthcare spending in India rose from INR 4,470 in 2019 to INR 4,863 in 2023, while the total healthcare expenditure increased from INR 5,96,440 crore to INR 6,55,822 crore. This indicates that healthcare facilities are adopting technological advancements, thereby driving the external defibrillator market in the country.
The LATAM and Caribbean regions have made strides toward universal health coverage by providing affordable healthcare services to people. Thus, with the rise in healthcare expenditure and health coverage, it is likely that the demand for these devices will also increase in the future. Further, the per capita income of people in the LATAM region has improved over the years, which will boost the market growth in the coming years. For instance, as per the International Monetary Fund, the GDP per capita in Brazil is around USD 1,135,000 in 2024.
Moreover, in Brazil, the cases of heart diseases are increasing. Obesity and overweight are the key factors responsible for heart diseases, CVD, CDH, HF, and stroke. Also, it is an emerging economy and has an improved healthcare system with quality care and low cost of surgeries. Thus, the Government of Brazil is promoting the adoption of defibrillators and creating awareness about life-threatening diseases.
The following regions and countries are covered in the report:
The external defibrillator market is fragmented on account of the availability of different types of products for different needs and varying regulatory scenario across countries. Additionally, the players target a range of end users for their products, such as clinics, public areas, hospitals, homecare settings, and nursing homes. Moreover, companies use many channels to reach customers, such as direct sales, online platforms, and third-party distributors.
Want a report tailored exactly to your business need?
Request Customization
Working with P&S Intelligence and their team was an absolute pleasure – their awareness of timelines and commitment to value greatly contributed to our project's success. Eagerly anticipating future collaborations.
McKinsey & Company
India
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws
Customize the Report to Align with Your Business Objectives
Request the Free Sample Pages